tirzepatide for binge eating disorder on ingestive behavior in adults with overweight or obesity: a randomized 6-week phase 1 trial Pharmacotherapies for Binge Eating Disorder:

By maintaining a healthy weight, you may be able to lower these risks and avoid obesity-related gynecologic issues later in life

Excess weight strains these joints, which contributes to pain, inflammation, and wear and tear

Results vary, but many patients experience 1520% reductions in total body weight with consistent treatment and proper lifestyle support

Allegations of Deceptive Marketing and Profit Prioritization Beyond inadequate warnings, plaintiffs allege Novo Nordisk engaged in deceptive marketing practices that created unrealistic expectations while downplaying serious risks

a list so long that it renders GLP1 the WORST in terms of side-effects amongst ALL other anti-diabetic & anti-obesity drugs